OPKO Health’s GeneDx Announces Participation in Illumina’s iHope Program on International Rare Disease Day

Go back to OPKO Health’s GeneDx Announces Participation in Illumina’s iHope Program on International Rare Disease Day

Opko Health (OPK) PT Lowered to $8 at Jefferies Following 4Q Miss

March 2, 2017 7:38 AM EST

Jefferies lowered its price target on Opko Health (NASDAQ: OPK) to $8.00 (from $10.00) while maintaining a Hold rating. 4Q revenues of $275M came in well below consensus estimates, mainly on weaker BRLI trends.

Analyst Brandon Couillard commented, "4Q16 revenues came in well below... More